Physician profile
Jay Suman Raval
NPI 1508002684
$189,118.94
in general payments reported to CMS, 2019-2025
10 companies · $13K in 2025
The $13K reported for 2025 was more than what 89% of Blood Banking & Transfusion Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $33K · 2021: $31K · 2022: $31K · 2023: $10K · 2024: $15K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Food and Beverage: $1,008 · Travel and Lodging: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,267.00 |
| Food and Beverage | $1,008.18 |
| Travel and Lodging | $778.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $154,107.24 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $20,672.74 | 2019-2020 | |
| Terumo Bct, INC. | $6,149.46 | 2019-2020 | |
| Medtronic, INC. | $2,903.47 | 2024-2025 | Azure Xt Dr Mri Surescan |
| Cerus Corporation | $2,631.25 | 2021-2023 | Intercept Blood System For Platelets |
| Bioverativ Therapeutics INC. | $2,355.00 | 2019 | |
| Grifols Diagnostic Solutions, INC. | $171.26 | 2019 | |
| Mallinckrodt Enterprises LLC | $94.16 | 2019 | |
| Alexion Pharmaceuticals, INC. | $34.36 | 2024 | Ultomiris |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Raval listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.